Pharma Marketing Network

MAY 3, 2023

Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential side effects of different drugs. However, pharmaceutical marketing is also regulated by several agencies to ensure that patients are not exposed to false or misleading information.

Safety 52

Safety Food and Drug Administration Pharmaceutical Marketing 52

European Pharmaceutical Review

OCTOBER 9, 2023

A new approach to potassium-channel openers for epilepsy Critically, XEN1101 combines the effectiveness of potassium-channel openers with the safety of more traditional drugs, stated study lead author and neurologist Dr Jacqueline French.

Side effects 110

Side effects Recruitment Safety Medicine 110

European Pharmaceutical Review

NOVEMBER 16, 2023

According to Vertex Pharmaceuticals and CRISPR Therapeutics, Casgevy is a genetically modified autologous CD34+ cell enriched population containing human hematopoietic stem and progenitor cells edited ex vivo by CRISPR/Cas9 at the erythroid-specific enhancer region of the BCL11A gene.

Safety 114

Safety Side effects Patients Medicine 114

Pharma Marketing Network

JULY 19, 2023

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales. In the pharmaceutical industry, content marketing can be particularly effective for driving sales.

Marketing 98

Marketing Pharmaceutical Sales Education 98

European Pharmaceutical Review

NOVEMBER 1, 2022

The committee advises that Cibinqo (abrocitinib), Jyseleca (filgotinib), Olumiant (baricitinib), Rinvoq (upadacitinib) and Xeljanz (tofacitinib), used for chronic inflammatory conditions, should have limited distribution to minimise risk of serious side effects such as cardiovascular diseases, blood clots, cancer and serious infections.

Side effects 98

Side effects Distribution Safety Patients 98

European Pharmaceutical Review

AUGUST 16, 2022

The regulator confirmed that the vaccine meets its standards of safety, quality and effectiveness. Safety monitoring showed that the side effects observed were the same as those seen for the original Moderna booster dose and were typically mild and self-resolving. No serious safety concerns were identified.

Safety 105

Safety Side effects Medicine Healthcare 105

European Pharmaceutical Review

NOVEMBER 18, 2022

The most common side effects observed were initial insomnia, irritability and dyskinesia. The efficacy and safety profile of Upstaza has been shown across clinical trials and compassionate use programmes. The post MHRA approves first gene therapy for infusion into the brain appeared first on European Pharmaceutical Review.

Side effects 126

Side effects Biopharma Safety Patients 126

European Pharmaceutical Review

APRIL 5, 2024

These interim data indicate early signs of potential clinical benefit with mRNA-3927, and importantly also demonstrate that mRNA-3927 has infrequent treatment-limiting side effects. The post mRNA therapy could provide intracellular protein replacement for rare disease appeared first on European Pharmaceutical Review.

Side effects 98

Side effects Safety Patients Leads 98

European Pharmaceutical Review

SEPTEMBER 20, 2022

This interchangeability refers to the fact that a reference medicine can be substituted by a biosimilar, without risk, side effects or outcomes different to the original drug. Analytical evidence by the EMA indicated that there was a lack of safety concerns regarding approval of biosimilars compared with their reference medicines.

Medicine 98

Medicine Side effects Safety Doctors 98

Pharmaceutical Technology

APRIL 11, 2023

Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies. During the two-year project, the companies will assess the mental health side effects of the asthma drug, montelukast.

Safety 59

Safety Food and Drug Administration FDA Side effects 59

Pharmaceutical Technology

NOVEMBER 23, 2022

The trial is designed to analyse the safety and efficacy of Hemgenix. A rise in liver enzymes, headache, increased blood enzyme level and flu-like symptoms among others were observed to be the most frequent side effects of the gene therapy. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Food and Drug Administration 105

Food and Drug Administration FDA Side effects Food 105

European Pharmaceutical Review

OCTOBER 10, 2022

Side effect data related to those given the non-US variation during pregnancy was consistent with data for individuals who were given the non-US formulation post labour. Post-partum, participants who received the placebo were subsequently vaccinated with the non-US formulation.

FDA 105

FDA Food and Drug Administration Side effects Food 105

European Pharmaceutical Review

NOVEMBER 2, 2023

The FDA said its approval of Wezlana is based on “a comprehensive review of scientific evidence demonstrating it is highly similar to Stelara and that there are no clinically meaningful differences between the two products in terms of safety, purity and potency.” Like Stelara, the most serious known side effect of Wezlana is infection.

Food and Drug Administration 98

Food and Drug Administration FDA Side effects Safety 98

Pharmaceutical Technology

AUGUST 15, 2022

After the vaccine was found to meet the standards of safety and quality, the regulatory agency granted the authorisation. According to the safety monitoring, side effects were generally mild and self-resolving, as well as in line with those reported for the original Moderna booster dose. 1 Omicron variant of concern.

Side effects 85

Side effects Safety Government Pharmaceutical 85

Pharmaceutical Technology

NOVEMBER 14, 2022

The CAR-T therapies for conditions like lupus continue to look promising, but their safety is a concern, says Gilkeson. In the five-patient report, mild cytokine release syndrome, a common side effect with CAR-Ts was observed, but the treatment was considered well tolerated.

Side effects 144

Side effects Patients Manufacturing Safety 144

European Pharmaceutical Review

MARCH 8, 2023

If the orally-delivered drug is confirmed have similar in safety and efficiency as the injectable forms, researchers stated that a PCSK9 inhibitor in a pill form could lower costs, increase convenience and expand patient access to the treatment. Plans for a Phase III clinical trial programme are underway.

Side effects 98

Side effects Safety Medicine Patients 98

European Pharmaceutical Review

DECEMBER 18, 2023

Treatment-related side effects included nausea and headache but were generally mild. “As In terms of safety, they noted that being a part of the group calmed their fears and increased their sense of preparedness to engage in therapy. Participants described generally positive experiences.

Food and Drug Administration 116

Food and Drug Administration Patients Side effects Safety 116

European Pharmaceutical Review

OCTOBER 18, 2022

The trial had a safety profile that was consistent with previous studies. Among the 170 axicabtagene ciloleucel-treated patients evaluable for safety, Grade ?3 The post EC approves CAR T-Cell therapy for B-cell lymphoma appeared first on European Pharmaceutical Review. Additionally, axicabtagene ciloleucel demonstrated a 2.5-fold

Side effects 111

Side effects Safety Patients Medical 111

European Pharmaceutical Review

DECEMBER 22, 2023

KarXT targets both the M1 and M4 muscarinic receptors, resulting in a differentiated safety and efficacy profile. It has demonstrated improvements in cognition and is not associated with common side effects of currently approved treatments like weight gain.

Food and Drug Administration 98

Food and Drug Administration Side effects Safety Food 98

European Pharmaceutical Review

OCTOBER 7, 2024

New results from a first-of-its-kind study reports that a CAR-T cell therapy provided similar efficacy and safety to relapsed or refractory multiple myeloma patients administered with the treatment in clinical trials.

Food and Drug Administration 105

Food and Drug Administration Side effects FDA Patients 105

European Pharmaceutical Review

APRIL 20, 2023

“These results are exciting… this treatment led to fewer days with migraine for people who had already tried up to four other types of drugs to prevent migraine and either had no improvement or had side effects that outweighed any benefits,” commented study author Dr Patricia Pozo-Rosich, PhD at Vall d’Hebron University Hospital in Barcelona, Spain.

Side effects 98

Side effects Safety Medical Pharmaceutical 98

European Pharmaceutical Review

DECEMBER 20, 2024

Overall, this enables delivery of biotherapeutics can result in broader brain distribution enabling better efficacy, improved safety profile and dosing convenience. The platform has potential to be utilised in future collaborations with other pharmaceutical firms, the company added.

Side effects 59

Side effects Distribution Safety Pharmaceutical 59

European Pharmaceutical Review

NOVEMBER 18, 2022

A clinical trial evaluated the safety and efficacy of Tzield in 76 patients with stage 2 type 1 diabetes. The most common side effects of Tzield were identified as lowered levels of certain white blood cells, rash and headache. Tzield is administered by intravenous infusion once per day for 14 days.

Food and Drug Administration 98

Food and Drug Administration FDA Side effects Food 98

European Pharmaceutical Review

NOVEMBER 14, 2022

CHMP’s safety update. The CHMP endorsed measures recommended by the EMA Pharmacovigilance Risk Assessment Committee (PRAC), to minimise the risk of serious side effects (cardiovascular conditions, blood clots, cancer and serious infections) of janus kinase (JAK) inhibitors for treating several chronic inflammatory disorders.

Medicine 98

Medicine Side effects Safety Pharmaceutical 98

European Pharmaceutical Review

NOVEMBER 1, 2023

The safety profile of the adapted vaccine is expected to be like that of the originally authorised Nuvaxovid, EMA said. The most common side effects with Nuvaxovid XBB.1.5 The post European approval for third adapted COVID-19 vaccine appeared first on European Pharmaceutical Review. The Comirnaty XBB.1.5-adapted

Side effects 105

Side effects Medicine Safety Marketing 105

European Pharmaceutical Review

JULY 20, 2022

Withdrawing drugs over safety concerns requires careful analysis of the health benefits and risks by regulators. Monitoring and studying the side effects of licensed medicines is an essential part of drug development to ensure public safety. Supporting regulators. It focused on data from France, Germany and the UK.

Medicine 97

Medicine Safety Side effects Electronics 97

European Pharmaceutical Review

DECEMBER 7, 2022

The common, expected side effects were within expectations for a vaccine in this age group. The Commission on Human Medicines (CHM), which endorsed the authorisation, advises ministers on the safety, efficacy and quality of medicinal products. Data that facilitated the line extension of Comirnaty ® for Covid-19.

Food and Drug Administration 98

Food and Drug Administration Patients Side effects Medicine 98

Pharmaceutical Technology

DECEMBER 7, 2022

On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.

Side effects 64

Side effects Food and Drug Administration Safety Physicians 64

European Pharmaceutical Review

FEBRUARY 9, 2023

Side effects seen in the trial included headache, dizziness, constipation, and increased urine output occurred with difelikefalin. Larger clinical trials are needed to better assess the efficacy and safety of difelikefalin in notalgia paresthetica. appeared first on European Pharmaceutical Review.

Food and Drug Administration 97

Food and Drug Administration FDA Side effects Medicine 97

Contrarian Sales Techniques

JANUARY 25, 2023

When I first started working as a pharmaceutical sales representative, I didn't fully understand the importance of product knowledge and accurate information. As a pharmaceutical sales representative, I have received extensive training on the products I represent.

Product Knowledge 52

Product Knowledge Pharmaceutical Sales Sales Pharmaceutical 52

European Pharmaceutical Review

JANUARY 25, 2024

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They detail the medication’s intended use, proper administration, potential side effects and precautions. percent as EU average with some Member States as high as 25 percent).

Healthcare 98

Healthcare Healthcare Safety Electronics 98

Pharmaceutical Technology

NOVEMBER 30, 2022

While masitinib works as a multi tyrosine kinase inhibitor, tolebrutinib and fenebrutinib are both Bruton’s tyrosine kinase (BTK) inhibitors, a novel MOA that is being investigated by multiple pharmaceutical companies for both PPMS and RMS.

Patients 98

Patients Side effects Safety Pharmaceutical 98

European Pharmaceutical Review

MARCH 10, 2023

Colloidal delivery nanosystems can carry different drugs, increase bioavailability, reduce frequency and potential side effects and improve patient’s compliance. The review summarised that effective management of ophthalmic diseases remains a difficulty, due to many ocular obstacles in the anterior and posterior sections of the eye.

Side effects 101

Side effects Management Leads Safety 101

Pharmaceutical Technology

JULY 28, 2022

This pipeline includes agents such as Abivax’s obefazimod; InDex Pharmaceuticals’ cobitolimod; three interleukin-23 (IL-23) inhibitors, namely AbbVie ’s Skyrizi (risankizumab), Eli Lilly ’s mirikizumab, and Janssen’s Tremfya (guselkumab); and Takeda ’s subcutaneous formulation of Entyvio (vedolizumab) in the US.

Food and Drug Administration 98

Food and Drug Administration Safety Side effects Marketing 98

European Pharmaceutical Review

JUNE 16, 2023

With the adoption of digital technologies gaining traction in many industries, pharmaceutical companies must take advantage of digitalisation within its research and development (R&D) sector. For organisations looking to standardise the measurement of safety data, what approach is the most impactful?

Safety 111

Safety Electronics Recruitment Patients 111

European Pharmaceutical Review

OCTOBER 21, 2022

At week 28, the study assessed the vaccine’s safety and levels of anti-HBV surface antibodies (HBsAbs). The most common side effects related to vaccination were injection site pain, malaise, fatigue, muscle aches and headaches. The international study will continue to examine the effects of two-dose HEPLISAV-B.

Patients 96

Patients Food and Drug Administration Side effects Food 96

Pharmaceutical Representative Training

JUNE 22, 2024

The Role of Certified Pharmaceutical Representatives in the Shifting Sales Landscape The US Bureau of Labor Statistics (BLS) projects the number of jobs for pharmaceutical sales representatives will grow by four percent by 2031, adding approximately 170,000 new job openings per year over this decade.

Sales 52

Sales Pharmaceutical Ethics Pharmaceutical Sales 52